- Home
- BBIO vs TENB Comparison
BBIO vs TENB Comparison
Compare BBIO & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- TENB
- Stock Information
- Founded
- BBIO 2015
- TENB 2002
- Country
- BBIO United States
- TENB United States
- Employees
- BBIO N/A
- TENB N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- TENB Computer Software: Prepackaged Software
- Sector
- BBIO Health Care
- TENB Technology
- Exchange
- BBIO Nasdaq
- TENB Nasdaq
- Market Cap
- BBIO 5.1B
- TENB 4.8B
- IPO Year
- BBIO 2019
- TENB 2018
- Fundamental
- Price
- BBIO $26.49
- TENB $41.05
- Analyst Decision
- BBIO Strong Buy
- TENB Buy
- Analyst Count
- BBIO 13
- TENB 16
- Target Price
- BBIO $47.92
- TENB $50.40
- AVG Volume (30 Days)
- BBIO 2.7M
- TENB 935.0K
- Earning Date
- BBIO 11-12-2024
- TENB 02-04-2025
- Dividend Yield
- BBIO N/A
- TENB N/A
- EPS Growth
- BBIO N/A
- TENB N/A
- EPS
- BBIO N/A
- TENB N/A
- Revenue
- BBIO $217,765,000.00
- TENB $877,596,000.00
- Revenue This Year
- BBIO $2,648.47
- TENB $14.43
- Revenue Next Year
- BBIO N/A
- TENB $9.64
- P/E Ratio
- BBIO N/A
- TENB N/A
- Revenue Growth
- BBIO 2209.77
- TENB 13.97
- 52 Week Low
- BBIO $21.62
- TENB $35.25
- 52 Week High
- BBIO $44.32
- TENB $53.50
- Technical
- Relative Strength Index (RSI)
- BBIO 49.05
- TENB 45.37
- Support Level
- BBIO $25.34
- TENB $39.63
- Resistance Level
- BBIO $28.15
- TENB $42.95
- Average True Range (ATR)
- BBIO 1.33
- TENB 1.24
- MACD
- BBIO -0.24
- TENB -0.26
- Stochastic Oscillator
- BBIO 24.73
- TENB 33.33
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.